Log in

Relevant bibliographies by topics / Beta agonist / Books

To see the other types of publications on this topic, follow the link: Beta agonist.

Books on the topic 'Beta agonist'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Beta agonist.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Elliott, Christopher Trevor. Detection of residues of the beta-agonist clenbuterol in medicated farm animals. The Author], 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Zug, Naser Abd-Asalam. Studies of the bronchodilator action of the long acting [beta]2-agonist (salmeterol) in normal human subjects. University of Manchester, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Grassitelli, A. Impiego di beta agonisti in alimentazione animale. Istituto superiore di sanità, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Akhlaghi, Shirin. The metabolic effects of beta-agonists and antagonists: Focus on beta-1 selectivity. University of Birmingham, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Gill, Hardyal Singh. Soft [beta]-adrenoceptor agonists for topical use in psoriasis. Aston University. Department of Pharmaceutical and Biological Sciences, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kummer, Friedrich, ed. Treatment of Asthma: The long-acting beta-2-agonists. Springer Vienna, 1998. http://dx.doi.org/10.1007/978-3-7091-7513-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

1946-, Frishman William H., ed. Beta₃-adrenergic agonism: A new concept in human pharmacotherapy. Futura, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Weersink, Els J. M. The natural variability in asthma: Two therapeutic approaches. E. Weersink, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Morton, Richard Hedley. Age-related effects of growth promoting [Beta]2-Adrenergic agonists on mammalian skeletal muscle. University of Manchester, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Food and Agriculture Organization of the United Nations, ed. Residue evaluation of certain veterinary drugs: Meeting 2010, evaluation of data on ractopamine residues in pig tissues. Food and Agriculture Organization of the United Nations, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Joint FAO/WHO Expert Committee on Food Additives. Meeting. Residue evaluation of certain veterinary drugs. Food and Agriculture Organization of the United Nations, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

McCaffrey, Patricia Marian. Studies of agonist and partial agonist activity at the beta-adrenoceptor in man. 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Beasley, Richard, and Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Beasley, Richard, and Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Beasley, Richard, and Neil E. Pearce. The Role of Beta Receptor Agonist Therapy in Asthma Mortality. Edited by Richard Beasley and Neil E. Pearce. CRC Press, 2020. http://dx.doi.org/10.1201/9780429281082.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Richard, Beasley, and Pearce Neil, eds. The Role of beta receptor agonist therapy in asthma mortality. CRC Press, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

The 2006-2011 World Outlook for Non-Prescription Beta Agonist Cough and Cold Preparations. Icon Group International, Inc., 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Parker, Philip M. The 2007-2012 World Outlook for Non-Prescription Beta Agonist Cough and Cold Preparations. ICON Group International, Inc., 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Fayssoil, Abdallah, and Djillali Annane. Inotropic agents in critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0036.

Full text

Abstract:

Inotropes are drugs commonly used in the intensive care unit. This class of agents includes a broad variety of molecules that improve cardiac index by increasing intracellular concentrations of cyclic AMP, or sensitivity to intracellular calcium, or by inhibiting the sodium/potassium pump. The main inotropic agents available are digoxin, catecholamines, and non-catecholergic drugs, e.g. phosphodiesterase inhibitors and levosimendan. In practice, dobutamine, a beta1 and beta2 agonist, is the inotrope of choice in patients with acute heart failure, or in patients with severe sepsis and evidence

APA, Harvard, Vancouver, ISO, and other styles

20

Parker, Philip M. The 2007-2012 Outlook for Non-Prescription Beta Agonist Cough and Cold Preparations in India. ICON Group International, Inc., 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Parker, Philip M. The 2007-2012 Outlook for Non-Prescription Beta Agonist Cough and Cold Preparations in Greater China. ICON Group International, Inc., 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Parker, Philip M. The 2007-2012 Outlook for Non-Prescription Beta Agonist Cough and Cold Preparations in the United States. ICON Group International, Inc., 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Dehydroepiandrosterone and a -agonist affect energy transduction and alter antioxidant enzymes: Influence of chronic training and acute exercise in rats. 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Dehydroepiandrosterone and a gbs-agonist affect energy transduction and alter antioxidant enzymes: Influence of chronic training and acute exercise in rats. 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Dehydroepiandrosterone and a beta-agonist affect energy transduction and alter antioxidant enzymes: Influence of chronic training and acute exercise in rats. 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Formoterol: A Long Acting B2-Agonist for the Management of Asthma : An International Symposium Held During the Joint Meeting of Sep and Sepcr, London. Hogrefe & Huber Pub, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

1936-, Saunders Kenneth B., European Society for Clinical Respiratory Physiology., and European Society of Pneumology, eds. Formoterol: A long-acting B2-agonist for the management of asthma : an international symposium held during the joint meeting of SEP and SEPCR, London, 1990. Hogrefe & Huber, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Romain, Pauwels, and O'Byrne Paul M. 1951-, eds. Beta₂-agonists in asthma treatment. Dekker, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

1946-, Barnes Peter J., Matthys Heinrich, and European Society of Pneumology. Congress, eds. Formoterol--a new-generation [beta] 2-agonist: An international symposium held during the 8th Congress of the European Society of Pneumology, Freiburg, Federal Republic of Germany, September 1989. Hogrefe & Huber, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

J, Davies Robert, and European Society of Pneumology. Congress, eds. Formoterol: Clinical profile of a new long-acting inhaled [beta]2-agonist : an international symposium held during the VIIth Congress of the European Society of Pneumology (SEP), Budapest, 1988. Hogrefe & Huber, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Badimon, Lina, Felix C. Tanner, Giovanni G. Camici, and Gemma Vilahur. Pathophysiology of thrombosis. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198755777.003.0018.

Full text

Abstract:

Ischaemic heart disease and stroke are major causes of death and morbidity worldwide. Coronary and cerebrovascular events are mainly a consequence of a sudden thrombotic occlusion of the vessel lumen. Arterial thrombosis usually develops on top of a disrupted atherosclerotic plaque because of the exposure of thrombogenic material, such as collagen fibrils and tissue factor (TF), to the flowing blood. TF, either expressed by subendothelial cells, macrophage- and/or vascular smooth muscle-derived foam-cells in atherosclerotic plaques, is a key element in the initiation of thrombosis due to its a

APA, Harvard, Vancouver, ISO, and other styles

32

Johnson, Malcolm, and Roger Small. Beta-Adrenoceptor Agonists and the Airways. Royal Society of Medicine Press Ltd, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Dr, Johnson Malcolm, Small Roger, British Pharmacological Society Meeting, and Glaxo Group Research Limited, eds. [Beta]-adrenoceptor agonists and the airways: Held as satellite meeting to the British Pharmacological Society Meeting, School of Biological Sciences, University of Manchester, 12-15 April 1994. Royal Society of Medicine Press, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

P, Hanrahan J., and Commission of the European Communities. Coordination of Agricultural Research., eds. Beta-agonists and their effects on animal growth and carcass quality: A seminar in the CEC Programme of Coordination of Research in Animal Husbandry, held in Brussels, 19-20 May 1987. Elsevier Applied Science, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

P, Hanrahan J., Commission of the European Communities., CEC Programme of Coordination of Research in Animal Husbandry., and Commission of the European Communities. Coordination of Agricultural Research., eds. Beta-agonists and their effects on animal growth and carcass quality. Elsevier Applied Science, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Friedrich, Kummer, and Vienna Asthma Forum (6th : 1996), eds. Treatment of asthma: The long-acting beta-2-agonists. Springer-Verlag, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

1944-, Costello J. F., and Mann Ronald D. 1928-, eds. Beta agonists in the treatment of asthma: The proceedings. Parthenon Pub. Group, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

(Editor), Friedrich Kummer, and Vienna Asthma Forum 1996 (Editor), eds. Treatment of Asthma: The Long-Acting Beta-2-Agonists. Springer, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Frishman, William H., and Daniel E. Goldberg. Beta3 Adrenergic Agonism: A New Concept in Human Pharmacotherapy. Futura Publishing Company, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

D, Strosberg A., ed. The B₃-adrenoreceptor. Taylor & Francis, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Liu, Cheng-chung. Interaction between glucocorticoid status and B-adrenergic agonists in control of muscle growth and protein degradation. 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

(Editor), Romain Pauwels, and Paul O'Byrne (Editor), eds. Beta 2-agonists in Asthma Treatment (Lung Biology in Health and Disease). Informa Healthcare, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Cropsey, Christopher L., and Patrick B. Knight. Beta Blocker/Calcium Channel Blocker Overdose. Edited by Matthew D. McEvoy and Cory M. Furse. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190226459.003.0088.

Full text

Abstract:

Beta blocker and calcium channel blocker overdose is a rare perioperative complication that manifests with symptoms of altered mental status, hypotension, bradycardia, and cardiovascular collapse. Although the clinical presentation is often similar, the underlying pathophysiology can differ between either cardiogenic or vasodilatory shock. Standard therapies such as calcium administration or beta-adrenergic agonists may be effective but often require much higher doses than normal. The evidence for targeted therapies, such as high-dose insulin infusion and glucagon, is mixed, but these should b

APA, Harvard, Vancouver, ISO, and other styles

44

Trifilieff, Alexandre. Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD. Springer, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

1944-, Costello J. F., and Royal Society of Medicine (Great Britain). Respiratory Section., eds. Sympathomimetic enantiomers in the treatment of asthma: The proceedings of a meeting held by the Respiratory Section of the Royal Society of Medicine, London, October 1995. Parthenon Pub. Group, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

1946-, Stephens David N., ed. Anxiolytic [Beta]-carbolines: From molecular biology to the clinic. Springer-Verlag, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

K, Shukla Vijay, та Canadian Coordinating Office for Health Technology Assessment, ред. Long-acting β₂₋agonists for maintenance therapy of stable chronic obstructive pulmonary disease : ba systematic review / cVijay K. Shukla...[et al.]. Canadian Coordinating Office for health Technology Assessment, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Redding, Amanda T., and Marc Hassid. Acute Severe Asthma and Bronchospasm. Edited by Matthew D. McEvoy and Cory M. Furse. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190226459.003.0079.

Full text

Abstract:

This chapter focuses on acute asthma and bronchospasm occurring in the perioperative period. Over 6% of the people in the United States have asthma, which is characterized by chronic inflammation, airway hyperresponsiveness, excessive mucus, and reversible airway obstruction. Due to generalized airway hyperreactivity, a history of asthma increases the risk of coughing, wheezing, bronchospasm, and oxygen desaturation. Although the incidence of bronchospasm associated with asthma is low, when it occurs it is often severe. A stepwise treatment algorithm is defined, which covers the use of first l

APA, Harvard, Vancouver, ISO, and other styles

49

McGrane, Tracy. Alcohol Withdrawal. Edited by Matthew D. McEvoy and Cory M. Furse. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190226459.003.0093.

Full text

Abstract:

This chapter, “Alcohol Withdrawal,” reviews the prevalence, presentation, pathophysiology, and anesthetic considerations for patients encountered at risk of alcohol withdrawal, as well as current intensive care unit practices caring for patients at risk of alcohol withdrawal to allow for improved perioperative crisis management. It reviews physiologic derangements in both acute and chronic alcoholism, and reviews the current evidence for prevention and treatment of alcohol withdrawal in the intensive care unit, including fixed-dose versus loading-dose versus symptom-based treatment using benzo

APA, Harvard, Vancouver, ISO, and other styles

50

Chapple, Christopher R., and Altaf Mangera. Urgency incontinence and overactive bladder. Edited by Christopher R. Chapple. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0040.

Full text

Abstract:

Overactive bladder (OAB) is very prevalent and may be very bothersome. In this chapter, we describe the various definitions associated with this condition, its assessment and management. The definitions for lower urinary tract symptoms have been standardized by the International Continence Society. OAB is a symptomatic diagnosis after all other pathology has been excluded. Important assessments include a frequency volume chart and in some cases urodynamic studies. Here we describe the important parameters which should be sought from a frequency volume chart. In addition, the relationship to th

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!